Mark Holoboski

Person

Irvine, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Therapeutic substituted cyclopentanes
- Patent number 9,765,065
- Issue date Sep 19, 2017
- Allergan, Inc.
- David W. Old
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic substituted cyclopentanes
- Patent number 9,591,935
- Issue date Mar 14, 2017
- Allergen, Inc.
- David W. Old
- A47 - FURNITURE DOMESTIC ARTICLES OR APPLIANCES COFFEE MILLS SPICE MILLS SUCT...
Information Patent Grant
Substituted cyclopentanes having prostaglandin activity
- Patent number 8,487,091
- Issue date Jul 16, 2013
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 8,193,373
- Issue date Jun 5, 2012
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 7,964,634
- Issue date Jun 21, 2011
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 7,960,378
- Issue date Jun 14, 2011
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy for glaucoma treatment
- Patent number 7,872,045
- Issue date Jan 18, 2011
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prostaglandin EP4 antagonists
- Patent number 7,612,082
- Issue date Nov 3, 2009
- Allergan, Inc.
- Larry A. Wheeler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...
- Patent number 7,514,462
- Issue date Apr 7, 2009
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Patent number 7,223,746
- Issue date May 29, 2007
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,3,4-substituted cyclopentanones as therapeutic agents
- Patent number 7,183,324
- Issue date Feb 27, 2007
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...
- Patent number 7,022,726
- Issue date Apr 4, 2006
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EP4 agonists as agents for lowering intraocular pressure
- Patent number 6,956,057
- Issue date Oct 18, 2005
- Allergan, Inc.
- David F. Woodward
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...
- Patent number 6,767,920
- Issue date Jul 27, 2004
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...
- Patent number 6,710,072
- Issue date Mar 23, 2004
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...
- Patent number 6,586,462
- Issue date Jul 1, 2003
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...
- Patent number 6,538,018
- Issue date Mar 25, 2003
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents fo...
- Patent number 6,410,591
- Issue date Jun 25, 2002
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Patent number 6,376,533
- Issue date Apr 23, 2002
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...
- Patent number 6,359,181
- Issue date Mar 19, 2002
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivat...
- Patent number 6,307,092
- Issue date Oct 23, 2001
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...
- Patent number 6,248,783
- Issue date Jun 19, 2001
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC SUBSTITUTED CYCLOPENTANES
- Publication number 20170144999
- Publication date May 25, 2017
- Allergan, Inc.
- David W. Old
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination therapy for glaucoma
- Publication number 20140235681
- Publication date Aug 21, 2014
- Allergan, Inc.
- SCOTT M. WHITCUP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
- Publication number 20130245283
- Publication date Sep 19, 2013
- Allergan, Inc.
- Wha-Bin Im
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy For Glaucoma
- Publication number 20110152328
- Publication date Jun 23, 2011
- Scott M. Whitcup
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
- Publication number 20100280250
- Publication date Nov 4, 2010
- Allergan, Inc.
- Wha-Bin Im
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20100063303
- Publication date Mar 11, 2010
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20090275646
- Publication date Nov 5, 2009
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20090239930
- Publication date Sep 24, 2009
- Allergan, Inc.
- Mark HOLOBOSKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY
- Publication number 20090227573
- Publication date Sep 10, 2009
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
- Publication number 20080132543
- Publication date Jun 5, 2008
- Wha Bin Im
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
- Publication number 20070232660
- Publication date Oct 4, 2007
- Allergan, Inc.
- Wha-Bin Im
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
omega-Cycloalkyl 17-Heteroaryl Prostaglandin E2 Analogs as EP2-Rece...
- Publication number 20070219262
- Publication date Sep 20, 2007
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,3,4-substituted cyclopentanones as therapeutic agents
- Publication number 20060111430
- Publication date May 25, 2006
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Prostaglandin EP4 antagonists
- Publication number 20060094742
- Publication date May 4, 2006
- Allergan, Inc.
- Larry A. Wheeler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of inflammatory bowel disease
- Publication number 20050222094
- Publication date Oct 6, 2005
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for glaucoma treatment
- Publication number 20050209194
- Publication date Sep 22, 2005
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor a...
- Publication number 20050113338
- Publication date May 26, 2005
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Publication number 20040106580
- Publication date Jun 3, 2004
- ALLERGAN INC.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EP4 agonists as agents for lowering intraocular pressure
- Publication number 20040102499
- Publication date May 27, 2004
- Allergan, Inc.
- David F. Woodward
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...
- Publication number 20030144254
- Publication date Jul 31, 2003
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Publication number 20030130239
- Publication date Jul 10, 2003
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for...
- Publication number 20030027853
- Publication date Feb 6, 2003
- Allergan Sales, Inc.
- Robert M. Burk
- Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC
Information Patent Application
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Publication number 20020187961
- Publication date Dec 12, 2002
- Robert M. Burk
- C07 - ORGANIC CHEMISTRY

Mark Holoboski

Person

Patents Grantslast 30 patents

Therapeutic substituted cyclopentanes

Therapeutic substituted cyclopentanes

Substituted cyclopentanes having prostaglandin activity

Therapeutic compounds

Therapeutic compounds

Therapeutic compounds

Combination therapy for glaucoma treatment

Prostaglandin EP4 antagonists

ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...

Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

2,3,4-substituted cyclopentanones as therapeutic agents

ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...

EP4 agonists as agents for lowering intraocular pressure

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...

&#x03A9;-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...

&#x03C9;-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...

3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents fo...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...

Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivat...

Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...

Patents Applicationslast 30 patents

THERAPEUTIC SUBSTITUTED CYCLOPENTANES

Combination therapy for glaucoma

THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS

Combination Therapy For Glaucoma

THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY

Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists

THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS

omega-Cycloalkyl 17-Heteroaryl Prostaglandin E2 Analogs as EP2-Rece...

2,3,4-substituted cyclopentanones as therapeutic agents

Prostaglandin EP4 antagonists

Treatment of inflammatory bowel disease

Combination therapy for glaucoma treatment

Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor a...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

EP4 agonists as agents for lowering intraocular pressure

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

Ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...

ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...